{"id":"https://openalex.org/W4393074955","doi":"https://doi.org/10.1158/1538-7445.am2024-6203","title":"Abstract 6203: An altered profile of ribosomal proteins and ERK-eIF4E translational control in an inflammatory breast cancer model of acquired resistance and reversal is associated with pathological complete response in patients","display_name":"Abstract 6203: An altered profile of ribosomal proteins and ERK-eIF4E translational control in an inflammatory breast cancer model of acquired resistance and reversal is associated with pathological complete response in patients","publication_year":2024,"publication_date":"2024-03-22","ids":{"openalex":"https://openalex.org/W4393074955","doi":"https://doi.org/10.1158/1538-7445.am2024-6203"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2024-6203","doi":"https://doi.org/10.1158/1538-7445.am2024-6203","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1158/1538-7445.am2024-6203","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5089632095","display_name":"Gayathri R. Devi","orcid":"https://orcid.org/0000-0001-9158-7289","observed_orcids":["https://orcid.org/0000-0001-9158-7289"]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gayathri R. Devi","raw_affiliation_strings":["1Duke University School of Medicine, Durham, NC;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Duke University School of Medicine, Durham, NC;","institution_ids":["https://openalex.org/I170897317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104262857","display_name":"Pritha PAI","orcid":"https://orcid.org/0009-0005-1719-4934","observed_orcids":["https://orcid.org/0009-0005-1719-4934"]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Pritha PAI","raw_affiliation_strings":["1Duke University School of Medicine, Durham, NC;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Duke University School of Medicine, Durham, NC;","institution_ids":["https://openalex.org/I170897317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065836613","display_name":"Matthew W. Foster","orcid":"https://orcid.org/0000-0003-0212-2346","observed_orcids":["https://orcid.org/0000-0003-0212-2346"]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Matthew W. Foster","raw_affiliation_strings":["1Duke University School of Medicine, Durham, NC;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Duke University School of Medicine, Durham, NC;","institution_ids":["https://openalex.org/I170897317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071624609","display_name":"Dorababu S. Sannareddy","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dorababu S. Sannareddy","raw_affiliation_strings":["1Duke University School of Medicine, Durham, NC;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Duke University School of Medicine, Durham, NC;","institution_ids":["https://openalex.org/I170897317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032591317","display_name":"Seayoung Lee","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Seayoung Lee","raw_affiliation_strings":["1Duke University School of Medicine, Durham, NC;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Duke University School of Medicine, Durham, NC;","institution_ids":["https://openalex.org/I170897317"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5077531941","display_name":"Steven Van Laere","orcid":"https://orcid.org/0000-0002-2640-0040","observed_orcids":["https://orcid.org/0000-0002-2640-0040","https://orcid.org/0000-0002-5711-2404"]},"institutions":[{"id":"https://openalex.org/I149213910","display_name":"University of Antwerp","ror":"https://ror.org/008x57b05","country_code":"BE","type":"education","lineage":["https://openalex.org/I149213910"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Steven V. Laere","raw_affiliation_strings":["2University of Antwerp, Antwerp, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2University of Antwerp, Antwerp, Belgium","institution_ids":["https://openalex.org/I149213910"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"84","issue":"6_Supplement","first_page":"6203","last_page":"6203"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.7182999849319458,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.7182999849319458,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.11550000309944153,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10521","display_name":"RNA and protein synthesis mechanisms","score":0.031199999153614044,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/inflammatory-breast-cancer","display_name":"inflammatory breast cancer","score":0.996999979019165},{"id":"https://openalex.org/keywords/acquired-drug-resistance","display_name":"acquired drug resistance","score":0.9539999961853027},{"id":"https://openalex.org/keywords/resistance-reversal","display_name":"resistance reversal","score":0.925000011920929},{"id":"https://openalex.org/keywords/ribosomal-proteins","display_name":"ribosomal proteins","score":0.9750000238418579},{"id":"https://openalex.org/keywords/mapk-signaling","display_name":"MAPK signaling","score":0.6650000214576721},{"id":"https://openalex.org/keywords/neoadjuvant-chemotherapy","display_name":"neoadjuvant chemotherapy","score":0.8619999885559082},{"id":"https://openalex.org/keywords/pathological-complete-response","display_name":"pathological complete response","score":0.9890000224113464},{"id":"https://openalex.org/keywords/multikinase-inhibitor","display_name":"multikinase inhibitor","score":0.7749999761581421},{"id":"https://openalex.org/keywords/lapatinib","display_name":"lapatinib","score":0.828000009059906},{"id":"https://openalex.org/keywords/egfr-tyrosine-kinase-inhibitors","display_name":"EGFR tyrosine kinase inhibitors","score":0.9660000205039978},{"id":"https://openalex.org/keywords/tumor-heterogeneity","display_name":"tumor heterogeneity","score":0.6069999933242798},{"id":"https://openalex.org/keywords/biomarkers","display_name":"biomarkers","score":0.7179999947547913},{"id":"https://openalex.org/keywords/precision-medicine","display_name":"precision medicine","score":0.4090000092983246}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6927999258041382},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.6210505962371826},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.5616905689239502},{"id":"https://openalex.org/C207886595","wikidata":"https://www.wikidata.org/wiki/Q1456138","display_name":"Pathological","level":2,"score":0.4850832521915436},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4102783203125},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.36651867628097534},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3663754463195801}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2024-6203","doi":"https://doi.org/10.1158/1538-7445.am2024-6203","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1158/1538-7445.am2024-6203","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4401093887","https://openalex.org/W2566311774","https://openalex.org/W2075870524","https://openalex.org/W7100206443","https://openalex.org/W153605727","https://openalex.org/W2317792503","https://openalex.org/W1644950302","https://openalex.org/W2042513563","https://openalex.org/W2107123646","https://openalex.org/W2561149536"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"Drug":[2],"resistance":[3,63,89,149,164,409],"is":[4,232,346,412],"a":[5,13,83,95,254],"major":[6],"challenge":[7],"in":[8,53,82,118,136,166,194,203,221,243,280,289,293,304,339,401,418],"inflammatory":[9,403],"breast":[10,404],"cancer":[11,38,281,349,405],"(IBC),":[12],"hyperproliferative":[14],"subtype":[15],"characterized":[16],"by":[17],"the":[18,32,56,129,163,173,218,244,269,315,335,424],"presence":[19,245],"of":[20,29,34,43,86,94,156,175,246,337,394,407,423],"diffuse":[21],"tumor":[22,35],"cell":[23,44,99,291],"clusters":[24],"that":[25,46,65,190,313],"show":[26],"high":[27,154],"level":[28,369],"heterogeneity.":[30],"As":[31],"degree":[33],"heterogeneity":[36],"during":[37],"progression":[39,84],"can":[40,47,66],"cause":[41],"evolution":[42],"states":[45,112],"either":[48],"compete":[49],"or":[50,70,321],"co-operate":[51],"resulting":[52],"therapeutic":[54,71,308],"failure,":[55],"study":[57,300],"objective":[58],"was":[59,80],"to":[60,124,172,183,210,228,306,317,342,356,359],"identify":[61],"drug":[62,88,205],"networks":[64],"serve":[67,318],"as":[68,234,319,348],"biomarkers":[69,320],"targets.":[72],"Methods:":[73],"Integrated":[74],"transcriptomic":[75],"and":[76,90,106,110,138,160,264,310,397,410],"proteomic":[77],"profiling":[78],"approach":[79],"conducted":[81],"model":[85,406],"acquired":[87,408],"its":[91],"reversal":[92,165,411],"comprised":[93],"treatment-na\u00efve":[96],"patient-derived":[97],"SUM149":[98],"line,":[100],"along":[101],"with":[102,148,153,252,286,414],"two":[103],"isogenic":[104],"derivatives":[105],"representing":[107],"drug-resistant":[108],"(rSUM149)":[109],"resistance-reversal":[111],"(rrSUM149).":[113],"Global":[114],"gene":[115],"expression":[116],"analysis":[117,179],"IBC":[119,222,235],"patients":[120,223,419],"(n=87)":[121,224],"recorded":[122],"responses":[123],"neoadjuvant":[125,229],"chemotherapy.":[126,230],"Based":[127],"on":[128,271],"data,":[130],"targeted":[131],"multikinase":[132,255],"inhibitors":[133],"were":[134,213],"evaluated":[135],"viability":[137],"signaling":[139,274,354],"assays.":[140],"Results:":[141],"We":[142],"identified":[143],"specific":[144],"ribosomal":[145,184,211,265,395],"proteins":[146,181,396],"associated":[147,413],"acquisition,":[150],"which":[151],"correlated":[152],"levels":[155],"pERK,":[157,258],"CDK1,":[158,263],"XIAP,":[159],"SOD2.":[161],"Conversely,":[162],"rrSUM149":[167],"showed":[168],"almost":[169],"complete":[170,416],"normalization":[171],"profile":[174,393],"SUM149.":[176],"However,":[177],"VIPER":[178],"revealed":[180],"related":[182],"processes":[185,212],"(AGO2,":[186],"Exportin":[187],"1,":[188],"RPL5)":[189],"did":[191],"not":[192],"revert":[193],"rrSUM149,":[195],"suggesting":[196],"this":[197,330],"pathway":[198],"may":[199],"have":[200,314],"pleiotropic":[201],"effects":[202],"governing":[204],"resistance.":[206],"Notably,":[207],"genes":[208,220],"linked":[209],"significantly":[214],"enriched":[215],"(P<0.001)":[216],"among":[217],"overexpressed":[219],"who":[225],"exhibited":[226],"pCR":[227],"This":[231],"crucial":[233,275],"tumors,":[236],"including":[237,242],"rSUM149,":[238],"exhibit":[239],"MAPK":[240],"hyperactivation":[241],"EGFR":[247],"tyrosine":[248],"kinase":[249],"inhibitors.":[250],"Treatment":[251],"Merestinib,":[253,338],"inhibitor,":[256],"suppressed":[257],"peIF4E,":[259],"downstream":[260],"targets":[261],"like":[262],"protein":[266,272],"IMP3":[267],"underscoring":[268],"impact":[270],"synthesis":[273],"for":[276,323,329,427],"countering":[277],"translational":[278,344,399],"dependence":[279,345],"cells.":[282],"Additionally,":[283],"Merestinib":[284],"synergized":[285],"EGFR-TKI":[287],"(lapatinib)":[288],"increasing":[290],"death":[292],"all":[294],"three":[295],"states.":[296],"Conclusion:":[297],"Overall,":[298],"our":[299],"describes":[301],"adaptive":[302],"changes":[303],"response":[305,417],"both":[307],"stress":[309,361],"therapy":[311],"break":[312],"potential":[316],"extended":[322],"pharmacological":[324],"interrogation":[325],"toward":[326],"precision":[327],"medicine":[328],"rare,":[331],"understudied":[332],"cancer.":[333],"Furthermore,":[334],"ability":[336],"clinical":[340],"trials,":[341],"target":[343],"attractive":[347],"cells":[350],"often":[351],"appropriate":[352],"these":[353],"pathways":[355],"gain":[357],"tolerance":[358],"various":[360],"stimuli.":[362],"Support:":[363],"NIH-R01CA264529;":[364],"DoD":[365],"Breast":[366],"Cancer":[367,428,446],"Breakthrough":[368],"2":[370],"Award":[371],"W81XWH2010153":[372],"Citation":[373],"Format:":[374],"Gayathri":[375],"R.":[376],"Devi,":[377],"Pritha":[378],"PAI,":[379],"Matthew":[380],"W.":[381],"Foster,":[382],"Dorababu":[383],"S.":[384],"Sannareddy,":[385],"Seayoung":[386],"Lee,":[387],"Steven":[388],"V.":[389],"Laere.":[390],"An":[391],"altered":[392],"ERK-eIF4E":[398],"control":[400],"an":[402],"pathological":[415],"[abstract].":[420],"In:":[421],"Proceedings":[422],"American":[425],"Association":[426],"Research":[429],"Annual":[430],"Meeting":[431],"2024;":[432],"Part":[433],"1":[434],"(Regular":[435],"Abstracts);":[436],"2024":[437],"Apr":[438],"5-10;":[439],"San":[440],"Diego,":[441],"CA.":[442],"Philadelphia":[443],"(PA):":[444],"AACR;":[445],"Res":[447],"2024;84(6_Suppl):Abstract":[448],"nr":[449],"6203.":[450]},"counts_by_year":[],"updated_date":"2026-11-05T12:25:35.769452","created_date":"2024-03-23T00:00:00"}